Identification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces Cerevisiae

Toxicon

Volumn 57, Issue 4, 2011, Pages 525-539

  Di, Rong ^a   Kyu, Eric ^a   Shete, Varsha ^a   Saidasan, Hemalatha ^a   Kahn, Peter C ^b   Tumer, Nilgun E ^a  

^a Rutgers University   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Apoptosis; E. coli O157:H7; Ribosome depurination; Ribosome inactivating protein; Ricin; Shiga toxin

Indexed keywords

ALPHA SARCIN; ARGININE; ASPARAGINE; GLUTAMIC ACID; RIBOSOME RNA; TYROSINE; VEROTOXIN 1; VEROTOXIN 2;

AMINO ACID ANALYSIS; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOTOXICITY; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA TRANSLATION; SACCHAROMYCES CEREVISIAE; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; STRUCTURE ANALYSIS; TOXIN ANALYSIS; YEAST CELL;

AMINO ACIDS; APOPTOSIS; IMAGE PROCESSING, COMPUTER-ASSISTED; MUTATION; PROTEIN CONFORMATION; PURINES; RIBOSOME INACTIVATING PROTEINS; RNA, RIBOSOMAL; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SHIGA TOXIN 1; SHIGA TOXIN 2;

SACCHAROMYCES CEREVISIAE;

EID: 79952359595     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.12.006     Document Type: Article

References (54)

1. Baykal U., Tumer N.E. The C-terminus of pokeweed antiviral protein has distinct roles in transport to the cytosol, ribosome depurination and cytotoxicity. Plant J. 2007, 49:995-1007.
2. Brigotti M., Carnicelli D., Alvergna P., Mazzaracchio R., Sperti S., Montanaro L. The RNA-N-glycosidase activity of Shiga-like toxin I: kinetic parameters of the native and activated toxin. Toxicon 1997, 35:1431-1437.
3. Cao C., Kurazono H., Yamasaki S., Kashiwagi K., Igarashi K., Takeda Y. Construction of mutant genes for a non-toxic verotoxin 2 variant (VT2vp1) of Escherichia coli and characterization of purified mutant toxins. Microbiol. Immunol. 1994, 38:441-447.
4. Chiou J.C., Li X.P., Remacha M., Ballesta J.P., Tumer N.E. The ribosomal stalk is required for ribosome binding, depurination of the rRNA and cytotoxicity of ricin A chain in Saccharomyces cerevisiae. Mol. Microbiol. 2008, 70:1441-1452.
5. Deresiewicz R.L., Calderwood S.B., Robertus J.D., Collier R.J. Mutations affecting the activity of the Shiga-like toxin I A-chain. Biochemistry 1992, 31:3272-3280.
6. Deresiewicz R.L., Austin P.R., Hovde C.J. The role of tyrosine-114 in the enzymatic activity of the Shiga-like toxin I A-chain. Mol. Gen. Genet. 1993, 241:467-473.
7. Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 1988, 171:45-50.
8. Fraser M.E., Chernaia M.M., Kozlov Y.V., James M.N. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution. Nat. Struct. Biol. 1994, 1:59-64.
9. Fraser M.E., Fujinaga M., Cherney M.M., Melton-Celsa A.R., Twiddy E.M., O'Brien A.D., James M.N. Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J. Biol. Chem. 2004, 279:27511-27517.
10. Fraser M.E., Cherney M.M., Marcato P., Mulvey G.L., Armstrong G.D., James M.N. Binding of adenine to Stx2, the protein toxin from Escherichia coli O157:H7. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun 2006, 62:627-630.
11. Garred O., van Deurs B., Sandvig K. Furin-induced cleavage and activation of Shiga toxin. J. Biol. Chem. 1995, 270:10817-10821.
12. Head S.C., Karmali M.A., Lingwood C.A. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J. Biol. Chem. 1991, 266:3617-3621.
13. Hovde C.J., Calderwood S.B., Mekalanos J.J., Collier R.J. Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I. Proc. Natl. Acad. Sci. U S A. 1988, 85:2568-2572.
14. Hudak K.A., Parikh B.A., Di R., Baricevic M., Santana M., Seskar M., Tumer N.E. Generation of pokeweed antiviral protein mutations in Saccharomyces cerevisiae: evidence that ribosome depurination is not sufficient for cytotoxicity. Nucleic Acids Res. 2004, 32:4244-4256.
15. Hur Y., Hwang D.J., Zoubenko O., Coetzer C., Uckun F.M., Tumer N.E. Isolation and characterization of pokeweed antiviral protein mutations in Saccharomyces cerevisiae: identification of residues important for toxicity. Proc. Natl. Acad. Sci. U S A. 1995, 92:8448-8452.
16. Jacewicz M., Clausen H., Nudelman E., Donohue-Rolfe A., Keusch G.T. Pathogenesis of Shigella diarrhea. XI. Isolation of a Shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J. Exp. Med. 1986, 163:1391-1404.
17. Johannes L., Romer W. Shiga toxins-from cell biology to biomedical applications. Nat. Rev. Microbiol. 2010, 8:105-116.
18. Kajander T., Kahn P.C., Passila S.H., Cohen D.C., Lehtio L., Adolfsen W., Warwicker J., Schell U., Goldman A. Buried charged surface in proteins. Structure 2000, 8:1203-1214.
19. Korennykh A.V., Piccirilli J.A., Correll C.C. The electrostatic character of the ribosomal surface enables extraordinarily rapid target location by ribotoxins. Nat. Struct. Mol. Biol. 2006, 13:436-443.
20. Korennykh A.V., Correll C.C., Piccirilli J.A. Evidence for the importance of electrostatics in the function of two distinct families of ribosome inactivating toxins. RNA 2007, 13:1391-1396.
21. LaPointe P., Wei X., Gariepy J. A role for the protease-sensitive loop region of Shiga-like toxin 1 in the retrotranslocation of its A1 domain from the endoplasmic reticulum lumen. J. Biol. Chem. 2005, 280:23310-23318.
22. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK- a program to check the sterochemical quality of protein structures. J. App. Cryst. 1993, 26:283-291.
23. Lee B., Richards F.M. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 1971, 55:379-400.
24. Lee S.Y., Lee M.S., Cherla R.P., Tesh V.L. Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells. Cell. Microbiol. 2008, 10:770-780.
25. Li X.P., Baricevic M., Saidasan H., Tumer N.E. Ribosome depurination is not sufficient for ricin-mediated cell death in Saccharomyces cerevisiae. Infect. Immun. 2007, 75:417-428.
26. Li X.P., Chiou J.C., Remacha M., Ballesta J.P., Tumer N.E. A two-step binding model proposed for the electrostatic interactions of ricin a chain with ribosomes. Biochemistry 2009, 48:3853-3863.
27. Lingwood C.A., Law H., Richardson S., Petric M., Brunton J.L., De Grandis S., Karmali M. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 1987, 262:8834-8839.
28. Maki D.G. Don't eat the spinach-controlling foodborne infectious disease. N. Engl. J. Med. 2006, 355:1952-1955.
29. McCluskey A.J., Poon G.M., Bolewska-Pedyczak E., Srikumar T., Jeram S.M., Raught B., Gariepy J. The catalytic subunit of shiga-like toxin 1 interacts with ribosomal stalk proteins and is inhibited by their conserved C-terminal domain. J. Mol. Biol. 2008, 378:375-386.
30. Nakagawa I., Nakata M., Kawabata S., Hamada S. Regulated expression of the Shiga toxin B gene induces apoptosis in mammalian fibroblastic cells. Mol. Microbiol. 1999, 33:1190-1199.
31. Nakajima H., Kiyokawa N., Katagiri Y.U., Taguchi T., Suzuki T., Sekino T., Mimori K., Ebata T., Saito M., Nakao H., Takeda T., Fujimoto J. Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance. J. Biol. Chem. 2001, 276:42915-42922.
32. Nataro J.P., Kaper J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 1998, 11:142-201.
33. O'Brien A.D., Tesh V.L., Donohue-Rolfe A., Jackson M.P., Olsnes S., Sandvig K., Lindberg A.A., Keusch G.T. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr. Top. Microbiol. Immunol. 1992, 180:65-94.
34. Ohmura M., Yamasaki S., Kurazono H., Kashiwagi K., Igarashi K., Takeda Y. Characterization of non-toxic mutant toxins of Vero toxin 1 that were constructed by replacing amino acids in the A subunit. Microb. Pathog. 1993, 15:169-176.
35. Parikh B.A., Coetzer C., Tumer N.E. Pokeweed antiviral protein regulates the stability of its own mRNA by a mechanism that requires depurination but can be separated from depurination of the alpha-sarcin/ricin loop of rRNA. J. Biol. Chem. 2002, 277:41428-41437.
36. Parikh B.A., Baykal U., Di R., Tumer N.E. Evidence for retro-translocation of pokeweed antiviral protein from endoplasmic reticulum into cytosol and separation of its activity on ribosomes from its activity on capped RNA. Biochemistry 2005, 44:2478-2490.
37. Parikh B.A., Tortora A., Li X.P., Tumer N.E. Ricin inhibits activation of the unfolded protein response by preventing splicing of the HAC1 mRNA. J. Biol. Chem. 2008, 283:6145-6153.
38. Paton J.C., Paton A.W. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 1998, 11:450-479.
39. Pickering L.K., Obrig T.G., Stapleton F.B. Hemolytic-uremic syndrome and enterohemorrhagic Escherichia coli. Pediatr. Infect. Dis. J. 1994, 13:459-475. quiz 476.
40. Pollard D.R., Johnson W.M., Lior H., Tyler S.D., Rozee K.R. Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J. Clin. Microbiol. 1990, 28:540-545.
41. Rajamohan F., Pugmire M.J., Kurinov I.V., Uckun F.M. Modeling and alanine scanning mutagenesis studies of recombinant pokeweed antiviral protein. J. Biol. Chem. 2000, 275:3382-3390.
42. Rao P.V., Jayaraj R., Bhaskar A.S., Kumar O., Bhattacharya R., Saxena P., Dash P.K., Vijayaraghavan R. Mechanism of ricin-induced apoptosis in human cervical cancer cells. Biochem. Pharmacol. 2005, 69:855-865.
43. Ready M.P., Kim Y., Robertus J.D. Site-directed mutagenesis of ricin A-chain and implications for the mechanism of action. Proteins 1991, 10:270-278.
44. Richards F.M. Calculation of molecular volumes and areas for structures of known geometry. Methods Enzymol. 1985, 115:440-464.
45. Sandvig K., van Deurs B. Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther. 2005, 12:865-872.
46. Sandvig K., Grimmer S., Lauvrak S.U., Torgersen M.L., Skretting G., van Deurs B., Iversen T.G. Pathways followed by ricin and Shiga toxin into cells. Histochem. Cell. Biol. 2002, 117:131-141.
47. Schlossman D., Withers D., Welsh P., Alexander A., Robertus J., Frankel A. Role of glutamic acid 177 of the ricin toxin A chain in enzymatic inactivation of ribosomes. Mol. Cell. Biol. 1989, 9:5012-5021.
48. Siegler R., Oakes R. Hemolytic uremic syndrome; pathogenesis, treatment, and outcome. Curr. Opin. Pediatr. 2005, 17:200-204.
49. Siegler R.L., Obrig T.G., Pysher T.J., Tesh V.L., Denkers N.D., Taylor F.B. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr. Nephrol. 2003, 18:92-96.
50. Simpson J.C., Roberts L.M., Romisch K., Davey J., Wolf D.H., Lord J.M. Ricin A chain utilizes the endoplasmic reticulum-associated protein degradation pathway to enter the cytosol of yeast. FEBS Lett. 1999, 459:80-84.
51. Smith M.J., Melton-Celsa A.R., Sinclair J.F., Carvalho H.M., Robinson C.M., O'Brien A.D. Monoclonal antibody 11E10, which neutralizes shiga toxin type 2 (Stx2), recognizes three regions on the Stx2 A subunit, blocks the enzymatic action of the toxin in vitro, and alters the overall cellular distribution of the toxin. Infect. Immun. 2009, 77:2730-2740.
52. Suhan M.L., Hovde C.J. Disruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicity. Infect. Immun. 1998, 66:5252-5259.
53. Tesh V.L., Burris J.A., Owens J.W., Gordon V.M., Wadolkowski E.A., O'Brien A.D., Samuel J.E. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 1993, 61:3392-3402.
54. Waddell T., Head S., Petric M., Cohen A., Lingwood C. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem. Biophys. Res. Commun. 1988, 152:674-679.